The massive PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are ...

Optum Rx announced on Wednesday that it will eliminate up to 25% of reauthorizations, initially focusing on 80 drugs. | Optum ...

Optum Rx is shifting its payment models to better meet the needs of pharmacies and consumers, the pharmacy benefit manager ...

Advertisement Article continues below this ad But one week after votes were tallied, their employer — Optum, a UnitedHealth ...

Optum Rx's new cost-based program uses an internal algorithm that leverages multiple available industry data sources, such as ...

Employers, including Express Scripts parent company Cigna, seek to manage GLP-1 costs through programs administered by the ...

Optum Rx has eliminated reauthorization for almost 70 drugs for chronic diseases, about 10% of its overall pharmacy prior ...

Optum Rx, the pharmacy benefit manager under UnitedHealth Group, is set to eliminate prior authorization requirements for ...

UnitedHealth (UNH) stock in focus as the company's Optum Rx unit introduces cost-based payment models to address pharmacy challenges. Read more here.

Optum Rx said it will similarly transition client arrangements such as employer and health plan customers - to ensure transparency and greater alignment to drug costs. It has already started ...

Optum Rx will increase reimbursements to pharmacies for brand-name drugs and cut them for generics.  Optum Rx said the new pharmacy payment models are in response to price increases set by brand name ...

Combined, these moves make Optum Rx the first comprehensive, transparent pharmacy services company that passes through savings to its clients and consumers. Supporting Pharmacies Across the U.S ...